25 October 2020

Creating a Safer COVID-era Workplace with Technology

Manufacturing leaders have always prioritized workplace safety. It is part of the culture, mindset, and even a driver of the industry’s technological innovations. Recent Capgemini research […]
24 October 2020

Think COVID-19 Cramped Your Travel Plans? You Ain’t Seen Nothing Yet.

For those who do business in China, decoupling brings ‘major headaches.’
23 October 2020

BoJ stress tests pressure top banks’ buffers – Risk.net

Internationally-active Japanese banks would have to dig into their capital buffers to weather severe economic and market crises, the latest stress test results from the Bank […]
23 October 2020

Pfizer Plans to Seek Authorization for COVID-19 Vaccine in November

US pharmaceutical giant Pfizer expects to file for emergency use authorization for its COVID-19 vaccine in late November, around two weeks after the November 3 US […]
23 October 2020

Banks’ cross-border exposures to shadow lenders fell in Q2 – Risk.net

Banks’ cross-border exposures to so-called shadow banks fell back slightly over the second quarter, having barrelled higher in Q1, data from the Bank for International Settlements (BIS) shows. Outstanding […]
23 October 2020

Barclays’ RWAs shrank on Q3 tailwinds, but loan failures loom – Risk.net

Barclays’ risk-weighted assets fell over the third quarter thanks to a series of one-off benefits, but the bank is braced for a resurgence once the full economic impact of […]
23 October 2020

Connected Worker Crucial to Digital Transformation

The pandemic has undoubtedly created a sense of urgency around the need for digital transformation including the significance of enabling a robust remote access environment. Of […]
23 October 2020

UBS market RWAs dropped 25% in Q3 as VAR cooled – Risk.net

Market risk-weighted assets (RWAs) at UBS dropped by more than one-quarter through Q3, as its regulatory value-at-risk indicators adjusted to recent calmer trading conditions. RWAs for market-making […]
23 October 2020

World Bank Approves $12B for COVID-19 Vaccines

The World Bank said Tuesday that it approved $12 billion for developing countries to finance the purchase and distribution of Covid-19 vaccines, tests and treatment. The […]